Clinical trial
S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer…
NCT00017173 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00017173 |
|---|---|
| Title | S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat |
| Official title | Phase II Trial Of Surgery With Perioperative RPR/INGN 201 (Ad5CMV-p53) Gene Therapy Followed By Chemoradiotherapy For Advanced, Resectable Squamous Cell Carcinoma Of The Oral Cavity, Oropharynx, Larynx, and Pharynx |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | Ad5CMV-p53 gene, cisplatin, conventional surgery, radiation therapy |
| Enrollment | 13 |
| Start date | Feb 1, 2003 |
| Primary completion | May 1, 2007 |
| Completion | Jul 1, 2011 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 14, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: